Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines.
Daisuke Inukai(Aichi Medical University), Tetsuya Ogawa(Nihon University), Yoshitaka Hosokawa(Aichi Medical University), Ryuzo Ueda(Nagoya University), Kenta Murotani(Kurume University), Rui Sano(Aichi Medical University), Hiromi Ueda(Tokyo University of Foreign Studies), Carol R. Bradford(The Ohio State University), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Kazuhiro Yoshikawa(Aichi Medical University), Akinobu Ota(Kinjo Gakuin University), Sivasundaram Karnan(Aichi Medical University), Hiroki Okamoto(Aichi Medical University), Susumu Suzuki(Aichi Medical University)
Cited by 4
Related Papers
Vegetarian Diets and Blood Pressure
|JAMA Internal Medicine|2014|524
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer
|International Journal of Radiation Oncology*Biology*Physics|2002|508
Clinical Predictors of Quality of Life in Patients With Head and Neck Cancer
|Archives of Otolaryngology - Head and Neck Surgery|2004|454
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
Single-Cycle Induction Chemotherapy Selects Patients With Advanced Laryngeal Cancer for Combined Chemoradiation: A New Treatment Paradigm
|Journal of Clinical Oncology|2005|267